melatonin has been researched along with Genome Instability in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Evidence suggests that genomic instability is responsible for cancer incidence after exposure to carcinogenic agents, and increases the risk of secondary cancers following treatment with radiotherapy or chemotherapy." | 2.61 | Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment. ( Farhood, B; Goradel, NH; Khanlarkhani, N; Mortezaee, K; Najafi, M; Sahebkar, A, 2019) |
| "Melatonin is a natural indoleamine produced by the pineal gland that has many functions, including regulation of the circadian rhythm." | 2.58 | Melatonin and Cancer Hallmarks. ( Talib, WH, 2018) |
| "While the emphasis of melatonin/cancer research has been on the role of the indoleamine in restraining breast cancer, this is changing quickly with many cancer types having been shown to be susceptible to inhibition by melatonin." | 2.55 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. ( Acuna-Castroviejo, D; Qin, L; Reiter, RJ; Rosales-Corral, SA; Tan, DX; Xu, K; Yang, SF, 2017) |
| "Relative to genomic instability, melatonin was effective in reducing DNA damage caused by ageing, presenting antigenotoxic and antimutagenic activities, independently of initiation age." | 1.56 | Melatonin supplementation over different time periods until ageing modulates genotoxic parameters in mice. ( Damiani, AP; de Andrade, VM; de Oliveira Sardinha, TT; de Pinho, RA; Gajski, G; Rohr, P; Strapazzon, G, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Damiani, AP | 1 |
| Strapazzon, G | 1 |
| de Oliveira Sardinha, TT | 1 |
| Rohr, P | 1 |
| Gajski, G | 1 |
| de Pinho, RA | 1 |
| de Andrade, VM | 1 |
| Reiter, RJ | 2 |
| Rosales-Corral, SA | 1 |
| Tan, DX | 1 |
| Acuna-Castroviejo, D | 1 |
| Qin, L | 1 |
| Yang, SF | 1 |
| Xu, K | 1 |
| Talib, WH | 1 |
| Giudice, A | 1 |
| Crispo, A | 1 |
| Grimaldi, M | 1 |
| Polo, A | 1 |
| Bimonte, S | 1 |
| Capunzo, M | 1 |
| Amore, A | 1 |
| D'Arena, G | 1 |
| Cerino, P | 1 |
| Budillon, A | 1 |
| Botti, G | 1 |
| Costantini, S | 1 |
| Montella, M | 1 |
| Majidinia, M | 1 |
| Shakouri, SK | 1 |
| Yousefi, B | 1 |
| Farhood, B | 1 |
| Goradel, NH | 1 |
| Mortezaee, K | 1 |
| Khanlarkhani, N | 1 |
| Najafi, M | 1 |
| Sahebkar, A | 1 |
5 reviews available for melatonin and Genome Instability
| Article | Year |
|---|---|
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, | 2017 |
Melatonin and Cancer Hallmarks.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Disease Pr | 2018 |
The Effect of Light Exposure at Night (LAN) on Carcinogenesis via Decreased Nocturnal Melatonin Synthesis.
Topics: Animals; Biological Clocks; Carcinogenesis; CLOCK Proteins; Energy Metabolism; Gene Expression Regul | 2018 |
The role of melatonin, a multitasking molecule, in retarding the processes of ageing.
Topics: Aging; Animals; Antioxidants; Brain; Circadian Rhythm; Energy Metabolism; Free Radicals; Genomic Ins | 2018 |
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Cell Transformation, Neoplast | 2019 |
1 other study available for melatonin and Genome Instability
| Article | Year |
|---|---|
Melatonin supplementation over different time periods until ageing modulates genotoxic parameters in mice.
Topics: Aging; Animals; Biomarkers; Comet Assay; Dietary Supplements; DNA Damage; Duration of Therapy; Genom | 2020 |